Health Advisory: CDC endorses second booster dose of mRNA COVID-19 vaccine for certain groups

Requested Actions


COVID-19 testing


COVID-19 therapies

Department of Health and Human Services (HHS) allocates monoclonal antibodies and oral antivirals to each state. DOH distributes doses to enrolled providers. Providers must enroll in Healthcare Partner Ordering Portal (HPoP) to manage COVID-19 therapies. Email for support enrolling.

Once enrolled, to request a supply of monoclonal antibodies or therapeutics, complete a smart sheet.

Supplies of all therapies are currently limited. Commercial and independent pharmacies may have oral antivirals. Hospital-associated systems may have monoclonal antibodies. All therapies must be dispensed by prescription. Therapies from pharmacies may be intended for home delivery. Patients with questions about accessing their medication should call the pharmacy.


Additional Information


COVID-19 prevention

Share with patients:


Immediately report COVID-19

Providers must fax positive lab results with demographic information to 509-381-3526.

Contacting the Health Department

Questions? Contact Yakima Health District at (509) 575-4040 or (800) 535-5016.


Additional Resources

CDC COVID-19 health equity resources.

Washington COVID-19 risk assessment dashboard.

CDC guidance for healthcare providers and facilities.

DOH COVID-19 data dashboard.

DOH COVID-19 page.

CDC COVID-19 page.

SARS-CoV-2 sequencing and variants in Washington.

FDA New Release: FDA authorizes revisions to Evusheld dosing

Fact Sheet for Patients, Parents and Caregivers Emergency Use Authorization (EUA) of Evusheld (tixagevimab co-packaged with cilgavimab) for Coronavirus Disease 2019 (COVID-19)

Fact Sheet for Healthcare Providers: Emergency Use Authorizations for Evusheld

Frequently Asked Questions on the Emergency Use Authorization for Evusheld (tixagevimab co-packaged with cilgavimab) for Pre-exposure Prophylaxis (PrEP) of COVID-19